Multiomics Enhances Drug Target Discovery by Revealing Therapeutic Vulnerabilities
Audio narration · Coming soon
This article discusses how multiomics approaches can aid researchers in identifying more promising drug targets. Dr. Shi-qi An explains that combining molecular data helps uncover therapeutic vulnerabilities and mechanisms of drug resistance, potentially improving drug development strategies.
Why this matters
PRISM scored this story 60/100 for interest.
Originally published by gnews
